drugset / Trial / NCT00853983
Phase I Study to Assess Absorption, Metabolism & Excretion of a Single Oral Dose [14C]AZD0530 in Healthy Male Volunteers
NaSingle-groupOpen-labelBasic science
Summary
The aim of this study is to show how the body absorbs, metabolises and excretes the drug \[14C\]AZD0530. As for all clinical trials, safety and tolerability of the drug will be evaluated.
Timeline
- Start
- 2009-03
- Primary completion
- —
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | saracatinib | Small molecule | — | Oral |
Indications
No indication recorded.